Lab Director Shares Insights at Fertility 2013 in Liverpool

pregnant woman laying downGet Pregnant Fast

Hey friends! We’ve got some exciting updates from the world of fertility. On January 3rd, Dr. Alex Thompson, the lab director at our center, took the stage at Fertility 2013 in Liverpool, England, to discuss a groundbreaking technique known as time-lapse embryo imaging. This innovative method, called Eeva, allows for the non-invasive identification of healthy embryos earlier in their development compared to traditional approaches.

In simple terms, time-lapse embryo imaging captures images of embryos at regular intervals and assembles them into a time-lapse video. With the help of specialized software, embryologists can monitor cell division timelines to predict blastocyst formation and select the best embryo(s) for implantation. These advancements could improve pregnancy success rates and support the use of single embryo transfers, reducing the risks associated with multiple births.

Dr. Thompson previously presented on this topic at the Fertility Society of Australia’s 2012 meeting in Auckland, where he was honored with an award for the Best Scientific Paper. His work, focusing on embryo culture and metabolism, has over two decades of experience behind it.

Fertility 2013, sponsored by notable organizations like the Association of Clinical Embryologists and the British Fertility Society, featured over 200 poster presentations and drew more than 400 experts in fertility and reproductive health. If you’re interested in learning more about home insemination, check out our post on welcoming a new approach to unexplained infertility here.

As always, for those considering home insemination, products like the BabyMaker Home Intracervical Insemination Syringe Kit can be a great resource. For more information on intrauterine insemination, this Healthline article is an excellent read.

In summary, we’re thrilled to see advancements like time-lapse embryo imaging making waves in the fertility field, and we can’t wait to see how they’ll enhance treatment options for aspiring parents.